Letter regarding article by Khan et al, "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis" [1]

Circulation

Volumn 113, Issue 20, 2006, Pages

  Apple, Fred S ^a   Jaffe, Allan S ^b   Herzog, Charles A ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

CARDIOVASCULAR RISK; DEATH; DIALYSIS; EVALUATION; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LETTER; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYMPTOM; BLOOD; CHRONIC KIDNEY FAILURE; MORTALITY; NOTE; PREDICTION AND FORECASTING;

BIOLOGICAL MARKERS; HUMANS; KIDNEY FAILURE, CHRONIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TROPONIN I; TROPONIN T;

EID: 33744467391     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.607341     Document Type: Letter

References (7)

1. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005;112:3088-3096.
2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(suppl 3):S1-S154. [See p S82].
3. Alpert JS, Thygesen K. Myocardial infarction redefined. J Am Coll Cardiol. 2000;21:1502-1513.
4. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (%CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005;51:1198-2200.
5. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941-2945.
6. Apple FS, Murakami MM, Pearce LA, Herzog CA. Prognostic value of high sensitivity C-reactive protein, N-terminal proBNP, and cardiac troponin T and I in end-stage renal disease for subsequent death over two years. Clin Chem. 2004;50:2279-2285.
7. Venge P, Lagerquist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II Substudy). Am J Cardiol. 2002;89:1035-1041.